UnionPay cardholders can now use their cards to pay for App Store, Apple Music, Apple TV, iCloud, and more across select regions

SHANGHAI, Nov. 20, 2025 /PRNewswire/ — UnionPay International today announced the expansion of its online payment services for Apple Services, including App Store and iCloud subscriptions. UnionPay cardholders in 15 international markets can now use their cards to pay for Apple’s digital content and subscription services — including App Store, Apple Music, Apple TV, iCloud, and more.

The service is now available in Australia, Cambodia, Georgia, Hong Kong SAR, Indonesia, Kazakhstan, Kenya, Macao SAR, Mongolia, Myanmar, Pakistan, the Philippines, Singapore, Thailand, and the UAE. Locally issued UnionPay cardholders in these regions can make online payments for App Services using their Apple ID. This initiative underscores UnionPay’s commitment to enhancing digital payment experiences and meeting the growing demand for seamless access to premium content and services worldwide. 

About UnionPay International

UnionPay International (UPI) is dedicated to expanding UnionPay’s global network and building seamless cross-border payment experiences. In partnership with over 2,600 partners worldwide, UPI enables card acceptance in 183 countries and regions with issuance in 84 countries and regions. UnionPay International provides high quality, cost effective and secure cross-border payment services to the world’s largest cardholder base and ensures convenient local services to a growing number of global UnionPay cardholders and merchants.

Beyond cards, UnionPay mobile payment services, UnionPay mobile QuickPass and QR code payment are accepted in over 100 countries and regions. Over 200 e-wallets in 37 countries and regions outside China’s mainland accept UnionPay cards, meeting the evolving needs of users in different markets.

 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Superior Efficacy and Long-acting: LongBio Announces Positive Topline Results from Phase II CSU Trial of Next-Generation Anti-IgE Therapy, LP-003 in Head-to-Head Comparison with Xolair®

PHILADELPHIA, March 2, 2026 /PRNewswire/ — LongBio Pharma (Suzhou) Co., Ltd. ("LongBio"), a clinical-stage…

Angel Yeast's Breakthrough in Yeast Protein Research: AngeoPro Shown to Promote Calcium Absorption, Aiding in Osteoporosis Prevention

YICHANG, China, Sept. 23, 2025 /PRNewswire/ — Angel Yeast (SH600298), a leading…

Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies

Key Highlights: Global first "immuno + anti-vascular" bispecific antibody approved: ivonescimab for…